Skip to main content

Advertisement

SpringerLink
Log in

Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology

  • Letter to the Editor
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Nucci M, Anaissie E (2007) Fusarium infections in immunocompromised patients. Clin Microbiol Rev 20(4):695–704

    Article  PubMed  CAS  Google Scholar 

  2. Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Araceli M, Rodriguez-Tudela JL (2006) Head-to-Head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeast and filamentous fungi. Antimicrob Agents Chemother 50(3):917–921

    Article  PubMed  CAS  Google Scholar 

  3. Clinical and Laboratory Standards Institute (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard, 2nd edn. CLSI, Wayne

    Google Scholar 

  4. Espinel-Ingroff A (2001) Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol 39(4):1360–1367

    Article  PubMed  CAS  Google Scholar 

  5. Arikan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex JH (1999) Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol 37(12):3946–3951

    PubMed  CAS  Google Scholar 

  6. Paphitou N, Ostrosky-Zeichner L, Paetznick V, Rodriguez JR, Chen E, Rex JH (2002) In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results. Antimicrob Agents Chemother 46(10):3298–3300

    Article  PubMed  CAS  Google Scholar 

  7. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzon A, Mellado E, Rodriguez-Tudela JL (2008) Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 61:805–809

    Article  PubMed  CAS  Google Scholar 

  8. Espinel-Ingroff A, Johnson E, Hockey H, Troke P (2008) Activities of voriconazole, itraconazole and amphotericin B in vitro against 590 moulds from 323 patients in the voriconazole Phase III clinical studies. J Antimicrob Chemother 61:616–620

    Article  PubMed  CAS  Google Scholar 

  9. Cordoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG (2008) In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Intl J Antimicrob Agents 31:171–174

    Article  CAS  Google Scholar 

  10. Tortorano A, Prigitano A, Dho G, Esposto MC, Gianni C, Grancini A, Ossi C, Viviani MA (2008) Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Antimicrob Agents Chemother 52(7):2683–2685

    Article  PubMed  CAS  Google Scholar 

  11. Iqbal NJ, Boey A, Park BJ, Brandt ME (2008) Determination of in vivo susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn Microbiol Infect Dis 62:348–350

    Article  PubMed  CAS  Google Scholar 

  12. Xie L, Zhai H, Zhao J, Sun S, Shi W, Dong X (2008) Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province, China. Am J Ophthalmol 146(2):260–265

    Article  PubMed  CAS  Google Scholar 

  13. Szekely A, Johnson E, Warnock D (1999) Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol 37(5):1480–1483

    PubMed  CAS  Google Scholar 

  14. Campo M, Lewis R, Kontoyiannis D (2010) Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998–2009. J Infect 60:331–337

    Article  PubMed  Google Scholar 

  15. Lortholary O, Obenga G, Biswas P (2010) International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole. Antimicrob Agents Chemother 54(10):4446–4450

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Pfizer for the voriconazole powder assay and for checking the English.

Author information

Authors and Affiliations

  1. Service de Parasitologie-Mycologie, CHU de Nancy, Hôpitaux de Brabois, 11 allée du Morvan, 54511, Vandœuvre-les-Nancy, France

    A. Debourgogne & M. Machouart

  2. Département de Microbiologie, EA4369 Relations Hôtes Environnement Micro-organismes, Faculté de Médecine, 9 avenue de la Forêt de Haye, 54505, Vandoeuvre-les-Nancy, France

    A. Debourgogne, A. Lozniewski & M. Machouart

  3. CBS-KNAW Fungal Biodiversity Centre, P.O. Box 85167, 3508 AD, Utrecht, Netherlands

    S. de Hoog

  4. Service de Bactériologie, CHU de Nancy, Hôpital Central, Avenue Maréchal de Lattre de Tassigny, 54000, Nancy, France

    A. Lozniewski

Authors
  1. A. Debourgogne
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. de Hoog
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Lozniewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Machouart
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Debourgogne.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Debourgogne, A., de Hoog, S., Lozniewski, A. et al. Amphotericin B and voriconazole susceptibility profiles for the Fusarium solani species complex: comparison between the E-test and CLSI M38-A2 microdilution methodology. Eur J Clin Microbiol Infect Dis 31, 615–618 (2012). https://doi.org/10.1007/s10096-011-1323-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-011-1323-x

Keywords

Search

Navigation